25.01
price up icon5.08%   1.21
after-market Dopo l'orario di chiusura: 25.01
loading
Precedente Chiudi:
$23.80
Aprire:
$23.8
Volume 24 ore:
3.59M
Relative Volume:
1.36
Capitalizzazione di mercato:
$2.53B
Reddito:
$352.57M
Utile/perdita netta:
$-143.01M
Rapporto P/E:
-13.82
EPS:
-1.81
Flusso di cassa netto:
$-153.40M
1 W Prestazione:
-10.55%
1M Prestazione:
+3.05%
6M Prestazione:
+25.49%
1 anno Prestazione:
+14.15%
Intervallo 1D:
Value
$23.50
$26.17
Intervallo di 1 settimana:
Value
$23.50
$27.57
Portata 52W:
Value
$13.53
$35.25

Beam Therapeutics Inc Stock (BEAM) Company Profile

Name
Nome
Beam Therapeutics Inc
Name
Telefono
857-327-8775
Name
Indirizzo
26 LANDSDOWNE STREET, CAMBRIDGE, MA
Name
Dipendente
509
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
BEAM's Discussions on Twitter

Confronta BEAM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
BEAM
Beam Therapeutics Inc
25.01 2.41B 352.57M -143.01M -153.40M -1.81
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Beam Therapeutics Inc Stock (BEAM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-09 Iniziato Jefferies Buy
2025-03-28 Aggiornamento BofA Securities Neutral → Buy
2025-03-10 Aggiornamento Scotiabank Sector Perform → Sector Outperform
2025-01-29 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2024-11-06 Aggiornamento Leerink Partners Market Perform → Outperform
2024-10-16 Iniziato Scotiabank Sector Outperform
2024-07-23 Iniziato H.C. Wainwright Buy
2024-01-29 Aggiornamento JP Morgan Neutral → Overweight
2023-12-15 Downgrade BofA Securities Buy → Neutral
2023-12-08 Downgrade Jefferies Buy → Hold
2023-10-20 Downgrade Cantor Fitzgerald Overweight → Neutral
2023-10-20 Downgrade Leerink Partners Outperform → Market Perform
2023-03-21 Iniziato Bernstein Mkt Perform
2023-02-01 Iniziato Cantor Fitzgerald Overweight
2022-12-20 Aggiornamento BMO Capital Markets Market Perform → Outperform
2022-12-13 Iniziato Citigroup Buy
2022-06-17 Iniziato BMO Capital Markets Market Perform
2022-04-28 Iniziato Credit Suisse Neutral
2022-01-05 Iniziato Guggenheim Buy
2021-10-19 Iniziato SVB Leerink Outperform
2021-09-24 Ripresa Stifel Buy
2021-09-10 Iniziato BofA Securities Buy
2021-05-11 Iniziato Redburn Buy
2021-05-04 Iniziato RBC Capital Mkts Sector Perform
2021-03-01 Downgrade Barclays Overweight → Equal Weight
2021-02-16 Iniziato Wells Fargo Overweight
2021-01-29 Downgrade JP Morgan Overweight → Neutral
2021-01-06 Iniziato Stifel Hold
2020-08-05 Iniziato William Blair Outperform
2020-03-02 Iniziato Barclays Overweight
2020-03-02 Iniziato JP Morgan Overweight
2020-03-02 Iniziato Jefferies Buy
2020-03-02 Iniziato Wedbush Outperform
Mostra tutto

Beam Therapeutics Inc Borsa (BEAM) Ultime notizie

pulisher
02:39 AM

Institutional scanner results for Beam Therapeutics Inc.2025 Market Sentiment & Breakout Confirmation Trade Signals - newser.com

02:39 AM
pulisher
12:55 PM

Why retail investors favor Beam Therapeutics Inc. stockTrade Ideas & Weekly Breakout Opportunity Watchlist - newser.com

12:55 PM
pulisher
01:58 AM

Published on: 2025-11-02 01:58:11 - newser.com

01:58 AM
pulisher
Nov 01, 2025

Real time social sentiment graph for Beam Therapeutics Inc.July 2025 Movers & Expert Approved Momentum Ideas - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

How to monitor Beam Therapeutics Inc. with trend dashboardsTrade Analysis Summary & Safe Capital Growth Tips - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Why Beam Therapeutics Inc. stock is favored by pension fundsQuarterly Performance Summary & Fast Moving Market Watchlists - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will Beam Therapeutics Inc. stock deliver long term returnsPortfolio Profit Report & Weekly Top Performers Watchlists - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Should you wait for a breakout in Beam Therapeutics Inc.Sell Signal & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

How buybacks impact Beam Therapeutics Inc. stock valueTrade Signal Summary & AI Forecasted Entry/Exit Points - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will Beam Therapeutics Inc. stock outperform Nasdaq indexInsider Buying & Stepwise Trade Signal Guides - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

What hedge fund activity signals for Beam Therapeutics Inc. stockJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Published on: 2025-10-31 03:50:40 - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Visualizing Beam Therapeutics Inc. stock with heatmaps2025 Institutional Moves & Daily Chart Pattern Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

ETFs Investing in Beam Therapeutics Inc. Stocks - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

Why retail investors pile into Beam Therapeutics Inc. stockTreasury Yields & Real-Time Volume Triggers - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Beam Therapeutics Inc. (BEAM) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Oct 30, 2025
pulisher
Oct 30, 2025

Beam Therapeutics Inc. (BEAM) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025
pulisher
Oct 30, 2025

Fmr Llc Sells 459 Shares of Beam Therapeutics (NASDAQ:BEAM) Stock - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Visual analytics tools that track Beam Therapeutics Inc. performanceIPO Watch & Advanced Swing Trade Entry Plans - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

BEAM Form 4: 459-share sale; indirect holdings include 1,139,443 - Stock Titan

Oct 29, 2025
pulisher
Oct 29, 2025

Beam Therapeutics (BEAM) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - sharewise.com

Oct 29, 2025
pulisher
Oct 29, 2025

Beam Therapeutics (BEAM) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

What is the fair value of Beam Therapeutics Inc. stock nowEarnings Summary Report & Weekly Top Gainers Alerts - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Beam Therapeutics Stock Dropped 13%Have You Assessed the Risk - Trefis

Oct 28, 2025
pulisher
Oct 28, 2025

Beam Therapeutics (NASDAQ:BEAM) Shares Gap DownHere's Why - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Beam Therapeutics Inc. (BEAM) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Yahoo Finance

Oct 28, 2025

Beam Therapeutics Inc Azioni (BEAM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Capitalizzazione:     |  Volume (24 ore):